OBJECTIVES : The clinical and economic burden that veteran ostomates impose on healthcare systems has previously been evaluated. The aim of this study was to complement existing research by gaining insights into the demographics, morbidity, and healthcare consumption of new ostomates. METHODS : Ostomates were identified based on anonymized claims data from 2012-2017, covering 4.8 million insurees representative of the German population. Ostomates with one newly created ileostomy, colostomy, or urostomy were identified based on ICPM-GM codes. Individuals with an ostomy procedure, device, or diagnosis within one year before index (=stoma creation) were excluded from the analysis. Only continuously insured individuals were included. Patients were followed-up for year 1 and 2 (FU1, FU2) after index. RESULTS : A total of 5,885 ostomates were included in the analysis; Ostomates had a mean age of 68 (SD=15.8) and 57% were male. 50% had a colostomy, 36% an ileostomy, and 14% a urostomy. 46% suffered from cancer, 3% from inflammatory bowel disease. 48% suffered from psychological diseases, where depression was the leading cause (25%). One year after stoma reversal, 10% of colostomists and 13% of ileostomists suffered from fecal incontinence. 12% of colostomists and 17% of ileostomists received pelvic floor training respectively. Average cost was 35,450€ (SD=35,334€) per ostomate during FU1 and 10,058€ (SD=19,047€) during FU2, compared to 6,942€ (SD=10,962€) in the year before index (p<0.05). Inpatient cost accounted for 82% of the total follow-up cost, outpatient cost for 6%, pharmaceuticals for 7%, medical device for 3%, and sick pay for 1%. CONCLUSIONS : Ostomates suffer higher morbidity and pose a significantly higher economic burden to society when compared to the year before index. Further studies are essential to confirm the necessity and evaluate the impact of in- and outpatient interventions to reduce preventable adverse events and costs. Preferably, interventions should be conducted before initial stoma creation.